This site is intended for health professionals only
Saturday 25 May 2019
Share |



Latest respiratory news

13.02.18: Draft NICE guidance paves the way for access to treatment with brodalumab on the National Health Service
19.01.18: Marketing authorisation based on global development program showing MVASI is highly similar to Avastin® (...
17.11.17: Robust analytical, pharmacological, non–clinical and clinical data demonstrated the similarity of Cyltezo® to...
15.11.17: Kavya Gopal from Sandoz to take-up chair role of Association
07.06.17: CT-P6 was similar in efficacy and safety to the reference trastuzumab in a Phase III, double blind,...

Respiratory analysis

Saturday 3 August 2013
Clinical trial design is a critical factor in the approval of biosimilars and pharmacists will need to be able to...
Saturday 3 August 2013
With the first marketing authorisation applications for biosimilar monoclonal antibodies now under consideration, what...
Wednesday 17 October 2012
With tighter cost constraints and more generic and biosimilar medicines available, including biosimilar monoclonal...
Monday 13 June 2011
Current low-molecular-weight heparins are safe and effective but there is controversy about the status of new products...
Monday 13 June 2011
As many drug companies look to develop biosimilar versions of monoclonal antibodies when their patents expire, it is...

You are leaving

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?


Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.



Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher